Correlation Between Eliem Therapeutics and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Olema Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Olema Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Olema Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Olema is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Olema Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 1.62 times more return on investment than Olema Pharmaceuticals. However, Eliem Therapeutics is 1.62 times more volatile than Olema Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 251.00 in Eliem Therapeutics on September 2, 2024 and sell it today you would earn a total of 53.00 from holding Eliem Therapeutics or generate 21.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.19% |
| Values | Daily Returns |
Eliem Therapeutics vs. Olema Pharmaceuticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Olema Pharmaceuticals |
Eliem Therapeutics and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Olema Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |